ABEONA THERAPEUTICS (ABEO) | Holzer & Holzer

ATLANTA, GA – – (Businesswire – September 24, 2019) – – Holzer & Holzer, LLC is investigating whether certain statements made by Abeona Therapeutics Inc. (“Abeona Therapeutics” or the “Company”) (NASDAQ: ABEO) complied with federal securities laws. On September 23, 2019, Abeona Therapeutics announced that it received a clinical hold letter from the FDA clarifying that the FDA will not approve Phase 3 clinical testing of the Company’s EB-101 therapy until it provides “additional data points.” The price of Abeona Therapeutics stock fell following the announcement. If you purchased shares of Abeona Therapeutics and suffered a loss on that investment, you are encouraged to contact Marshall P. Dees, Esq. at mdees@holzerlaw.com or Luke R. Kennedy at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

View Complaint

View Representation Agreement

Provide Your Information To Take Action

Name*
First Last
Email*
Phone*
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
Plaintiff Certifies That:
1. Plaintiff has reviewed the complaint and authorized its filing.
2. Plaintiff did not acquire the security that is the subject of this action at the direction of plaintiff's counsel or in order to participate in this private action or any other litigation under the federal securities laws.
3. Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.
4. Plaintiff represents and warrants that he/she/it is fully authorized to enter into and execute this certification.
5. Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond the Plaintiff's pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the class as ordered or approved by the court.
6. Plaintiff has made no transaction(s) during the Class Period in the debt or equity securities that are the subject of this action except those set forth below:
Class Period Purchases:*
Date Purchased Number of Shares Acquired Acquisition Price Per Share
Class Period Sales:
Date Sold Number of Shares Sold Selling Price Per Share
7. During the three years prior to the date of this Certification, Plaintiff has not sought to serve or served as a representative party for a class in an action filed under the federal securities laws except if detailed below (enter none if not applicable):*
I declare under penalty of perjury, under the laws of the United States, that the information entered is accurate.*
- I agree.
By clicking on the button below, I intend to sign and execute this Agreement and retain Holzer & Holzer, LLC to proceed on my behalf.*
- I agree.
Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Signature*

Date Purchased	Number of Shares Acquired	Acquisition Price Per Share